Peeling Back The Layers: Exploring Sutro Biopharma Through Analyst Insights
Peeling Back The Layers: Exploring Sutro Biopharma Through Analyst Insights
揭開層層面紗：通過分析師洞察探索sutro biopharma
A clear picture of Sutro Biopharma's perception among financial...Sutro Biopharma (NASDAQ:STRO) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
在上個季度，sutro biopharma (納斯達克:STRO)接受了5位分析師的分析，從看好到看淡，觀點各異。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級概況，突出了過去30天內情緒的變化，並將其與之前的月份進行了比較。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $13.6, a high estimate of $17.00, and a low estimate of $12.00. This current average has decreased by 4.23% from the previous average price target of $14.20.
分析師評級確定的12個月目標價格揭示了更多見解，平均目標爲$13.6美元，最高估價爲$17.00美元，最低估價爲$12.00美元。當前的平均目標價格比之前的$14.20美元的平均目標價格下降了4.23%。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級：詳細剖析
A clear picture of Sutro Biopharma's perception among financial...
通過對最新分析師行動...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間